Literature DB >> 9160288

Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment--botulinum toxin A injections of the parotid glands.

K O Bushara1.   

Abstract

The inhibitory action of botulinum toxin is not confined to the neuromuscular junction. The toxin has long been known to block all the autonomic cholinergic fibers, including the major secretomotor parasympathetic fibers to salivary glands. The parotids are the largest of the salivary glands and their selective chemodenervation with botulinum toxin A is likely to result in substantial reduction of saliva production. Injection of the parotid glands with botulinum toxin is proposed as an new treatment for sialorrhea in patients with amyotrophic lateral sclerosis and other neurological diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9160288     DOI: 10.1016/s0306-9877(97)90103-1

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  23 in total

1.  Effect of botulinum toxin type a on morphology of salivary glands in patients with cerebral palsy.

Authors:  Zee-Ihn Lee; Dong-Hyun Cho; Won-Duck Choi; Dong-Hwi Park; Seung-Deuk Byun
Journal:  Ann Rehabil Med       Date:  2011-10-31

Review 2.  Evidence for the effectiveness of botulinum toxin for sialorrhoea.

Authors:  D D Truong; R Bhidayasiri
Journal:  J Neural Transm (Vienna)       Date:  2008-02-04       Impact factor: 3.575

Review 3.  Diagnostic investigation and multidisciplinary management in motor neuron disease.

Authors:  J A Rocha; C Reis; F Simões; J Fonseca; J Mendes Ribeiro
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

4.  Anatomical localization of submandibular gland for botulinum toxin injection.

Authors:  J H Lee; B N Lee; S O Kwon; R H Chung; S H Han
Journal:  Surg Radiol Anat       Date:  2010-03-11       Impact factor: 1.246

Review 5.  The use of botulinum toxin injections to manage drooling in amyotrophic lateral sclerosis/motor neurone disease: a systematic review.

Authors:  Nina Squires; Miles Humberstone; Adrian Wills; Antony Arthur
Journal:  Dysphagia       Date:  2014-05-22       Impact factor: 3.438

Review 6.  Botulinum toxin therapy: functional silencing of salivary disorders.

Authors:  A Lovato; D A Restivo; G Ottaviano; G Marioni; R Marchese-Ragona
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-04       Impact factor: 2.124

7.  Botulinum toxin in the treatment of drooling in tetraplegic patients with brain injury.

Authors:  Sung Hwa Ko; Yong Beom Shin; Ji Hong Min; Myung Jun Shin; Jae Hyeok Chang; Yong-Il Shin; Hyun-Yoon Ko
Journal:  Ann Rehabil Med       Date:  2013-12-23

Review 8.  [Treatment of sialorrhea with botulinum toxin: an overview].

Authors:  J Hagenah; K G Kahl; S Steinlechner; R Lencer; C Klein
Journal:  Nervenarzt       Date:  2005-04       Impact factor: 1.214

9.  Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis.

Authors:  João Costa; Maria Luz Rocha; Joaquim Ferreira; Teresinha Evangelista; Miguel Coelho; Mamede de Carvalho
Journal:  J Neurol       Date:  2008-02-19       Impact factor: 4.849

10.  Comparing the Effect of Botulinum Toxin Type B Injection at Different Dosages for Patient with Drooling due to Brain Lesion.

Authors:  Hee Dong Park; Hyo Jae Kim; Sang Jun Park; Yong Min Choi
Journal:  Ann Rehabil Med       Date:  2012-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.